Correlation Between Alnylam Pharmaceuticals and Eyepoint Pharmaceuticals
Can any of the company-specific risk be diversified away by investing in both Alnylam Pharmaceuticals and Eyepoint Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Alnylam Pharmaceuticals and Eyepoint Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Alnylam Pharmaceuticals and Eyepoint Pharmaceuticals, you can compare the effects of market volatilities on Alnylam Pharmaceuticals and Eyepoint Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Alnylam Pharmaceuticals with a short position of Eyepoint Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Alnylam Pharmaceuticals and Eyepoint Pharmaceuticals.
Diversification Opportunities for Alnylam Pharmaceuticals and Eyepoint Pharmaceuticals
-0.21 | Correlation Coefficient |
Very good diversification
The 3 months correlation between Alnylam and Eyepoint is -0.21. Overlapping area represents the amount of risk that can be diversified away by holding Alnylam Pharmaceuticals and Eyepoint Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Eyepoint Pharmaceuticals and Alnylam Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Alnylam Pharmaceuticals are associated (or correlated) with Eyepoint Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Eyepoint Pharmaceuticals has no effect on the direction of Alnylam Pharmaceuticals i.e., Alnylam Pharmaceuticals and Eyepoint Pharmaceuticals go up and down completely randomly.
Pair Corralation between Alnylam Pharmaceuticals and Eyepoint Pharmaceuticals
Given the investment horizon of 90 days Alnylam Pharmaceuticals is expected to generate 0.47 times more return on investment than Eyepoint Pharmaceuticals. However, Alnylam Pharmaceuticals is 2.14 times less risky than Eyepoint Pharmaceuticals. It trades about 0.0 of its potential returns per unit of risk. Eyepoint Pharmaceuticals is currently generating about -0.12 per unit of risk. If you would invest 25,374 in Alnylam Pharmaceuticals on November 27, 2024 and sell it today you would lose (480.00) from holding Alnylam Pharmaceuticals or give up 1.89% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Alnylam Pharmaceuticals vs. Eyepoint Pharmaceuticals
Performance |
| Timeline |
| Alnylam Pharmaceuticals |
| Eyepoint Pharmaceuticals |
Alnylam Pharmaceuticals and Eyepoint Pharmaceuticals Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Alnylam Pharmaceuticals and Eyepoint Pharmaceuticals
The main advantage of trading using opposite Alnylam Pharmaceuticals and Eyepoint Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Alnylam Pharmaceuticals position performs unexpectedly, Eyepoint Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Eyepoint Pharmaceuticals will offset losses from the drop in Eyepoint Pharmaceuticals' long position.| Alnylam Pharmaceuticals vs. ProQR Therapeutics BV | Alnylam Pharmaceuticals vs. Wave Life Sciences | Alnylam Pharmaceuticals vs. Blueprint Medicines Corp | Alnylam Pharmaceuticals vs. Apellis Pharmaceuticals |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Idea Optimizer module to use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio .
Other Complementary Tools
| Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
| AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
| Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments | |
| Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments |